EGFR and coronary artery disorder: Research by Xu H et al. demonstrated that Tan IIA regulates the proliferation and apoptosis of cardiac H9c2 cells through the miR-133a-3p/EGFR axis, thereby improving the progression of CAD, highlighting its potential as an intervention for CAD treatment [12].